Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
Daphne T. Adelman
Dirk Van Genechten
Clémentine M. Megret
Xuan-Mai T. Truong Thanh
Philippa Hand
Wendy A. Martin
10.6084/m9.figshare.9902078.v4
https://adisjournals.figshare.com/articles/media/Co-Creation_of_a_Lanreotide_Autogel_Depot_Syringe_for_the_Treatment_of_Acromegaly_and_Neuroendocrine_Tumours_Through_Collaborative_Human_Factor_Studies/9902078
<p>Video and Infographic published with permission by Ipsen, who hold the full copyright.<strong><br></strong></p><p><br></p><p><strong>Provide enhanced digital features for this article</strong><br></p><p>
If you are an author of this publication and would like to provide additional
enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to
ensure the content is of the highest scientific standard and all features are
marked as ‘peer reviewed’ to ensure readers are aware that the content has been
reviewed to the same level as the articles they are being presented alongside.
Moreover, all sponsorship and disclosure information is included to provide
complete transparency and adherence to good publication practices. This ensures
that however the content is reached the reader has a full understanding of its
origin. No fees are charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are not limited to:<br>
• Slide decks<br>
• Audio abstracts<br>
• Audio slides</p>
2019-12-16 09:13:20
Acromegaly
Autogel
Caregivers
Depot
Lanreotide
Neuroendocrine tumours
Nurses
Patients
Syringe
Plain Language Summary